ArticleInvestigative ophthalmology & visual science2026
Machine Learning-Based Cytokine Endotyping of Thyroid Eye Disease.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Thyroid eye disease (TED) exhibits profound phenotypic heterogeneity that conventional binary thyrotropin receptor antibody fails to capture. We aimed to deconstruct this heterogeneity by establishing a cytokine-derived molecular taxonomy. Methods: We profiled 102 plasma cytokines in 101 TED patients using a Luminex assay. Integrative machine learning identified key cytokine signatures. Unsupervised K-means clustering defined four discrete endotypes. A diagnostic nomogram (named the cytokine-derived cluster [CKC] score) was developed and evaluated in an independent external cohort. Results: Machine learning identified a robust four-cytokine signature (vascular cell adhesion molecule 1, C-C motif chemokine ligand 19, C-X3-C motif chemokine ligand 1, chemokine (C-X-C motif) ligand 13). This signature stratified TED patients into four distinct endotypes: CKC1 (inflammatory; n = 34) showed the highest Clinical Activity Score and gaze-evoked pain (23.5%); CKC2 (proliferative; n = 32) demonstrated prominent structural changes with the highest proptosis and diplopia (81.3%); CKC3 (fibrogenic; n = 20) exhibited chronic fibrotic features; and CKC4 (metabolic; n = 15) presented with metabolic comorbidities (diabetes 53.3%). The CKC score nomogram successfully predicted endotypes assignment, achieving an internal area under the receiver operating characteristic curve of 0.742 and maintaining robust discriminative power in the external validation cohort. Conclusions: Using machine learning, we identified a four-cytokine signature that robustly stratifies TED patients into four immunologically and clinically distinct endotypes. The CKC scoring model, derived from this signature, enables the accurate and reproducible prediction of endotype membership.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.